U.S. pharmaceutical industry in Michael Porter's Five Forces Analysis

Published on December 10, 2009 at 8:31 AM · No Comments

Research and Markets (http://www.researchandmarkets.com/research/ba9e6e/pharmaceutical_ind) has announced the addition of the "Pharmaceutical Industry in the United States - Porter's Five Forces Strategy Analysis" report to their offering.

Pharmaceutical is one of the most intense "Knowledge Driven" industries, which is continually in a state of dynamic transition. Diversities in life forms and diseases pose stiff challenge to the design of specific and targeted solutions. The process of "drug discovery/invention" is elaborate requiring on an average 8-10 years at a cost of US$ 300 million to reach a new drug to the market.

Aruvian Research analyzes the Pharmaceutical Industry in United States in the Michael Porter's Five Forces Analysis. It uses concepts developed in Industrial Organization (IO) economics to derive five forces that determine the competitive intensity and therefore attractiveness of a market. Porter referred to these forces as the microenvironment, to contrast it with the more general term macroenvironment. They consist of those forces close to a company that affect its ability to serve its customers and make a profit. A change in any of the forces normally requires a company to re-assess the marketplace.

Key Topics Covered:

Executive Summary

Introduction to the Industry

  • Industry Definition
  • Industry Profile
  • Future Outlook

Porter's Five Forces Strategy Analysis

  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Competitive Rivalry in the Industry
  • Threat of New Entrants
  • Threat of Substitutes

Posted in: Pharmaceutical News

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Bahasa | Русский | Svenska | Polski
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment